Help Cure Dupuytren Disease
SUPPORT RESEARCH TO CURE DUPUYTREN DISEASE!
The Dupuytren Research Group is a 501(c)(3) nonprofit public charity conducting research to find a Dupuytren cure. Our first goal is to develop a Dupuytren blood test, which is the most important step toward developing a Dupuytren cure. We are supported entirely by charitable giving. Gift by credit or debit card or use other options to invest now in research for a cure.
Stop-start funding makes it difficult to plan research. Become a Sustaining Member. It’s easier on you and your budget, and guarantee the sustainability of our work. Click Here to extend your impact through our recurring giving program.
Check: (Do not send cash)
Make your check or money order payable to Dupuytren Research Group and mail to:
Dupuytren Research Group
1850 Forest Hill Blvd STE 201
West Palm Beach, FL 33406-6064
ACH Bank Transfer:
Instruct your bank to use the secure Dupuytren Research Group UPIC number
Routing/Transit number ABA 021052053
For credit to Account Number 80274546
Stock Transfer:
Call Brian Baughman at 561-741-1390 to discuss
Qualified charitable distributions allow donors at least 70.5 years old to give charities up to $100,000 yearly directly from their IRAs without counting taxable income.
Call Brian Baughman at 561-741-1390 to discuss
Shop to support: These companies donate to the Dupuytren Research Group for every purchase made through the sponsor pages linked here:
Candid (formerly Guidestar) has awarded the Dupuytren Research Group a Gold GuideStar Nonprofit Profile rating, the leading symbol of nonprofit transparency and accountability.
Please contact the Dupuytren Research Group main office 561-429-8279 to discuss other forms of charitable giving.
FDACS DTN2822236 CH30655. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES (http://www.800helpfla.com) BY CALLING TOLL-FREE WITHIN THE STATE 1-800-435-7352. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.
